Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
Date:10/12/2008

SEATTLE, Oct. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) has been selected to present at three upcoming investor conferences. The conferences include the 7th Annual BIO Investor Forum in San Francisco in October, the 19th Annual Oppenheimer & Co. Healthcare Conference, and the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference in November, both in New York City.

The presentations will be webcast live with slides, and available for replay after the presentation at http://www.celltherapeutics.com.

BIO Investor Forum

CTI Presentation: Thursday, October 30, 2008

8:00 AM PT/11:00 AM ET/4:00 PM CET

Room TBA, Palace Hotel, San Francisco

Oppenheimer & Co. Healthcare Conference

CTI Presentation: Monday, November 3, 2008

8:00 AM ET/2:00 PM CET/5:00 AM PT

Astor Room, Waldorf-Astoria Hotel, New York City

Acumen BioFin Rodman & Renshaw Healthcare Conference

CTI Presentation: Tuesday, November 11, 2008

10:45 AM EST/4:45 PM CET/7:45 AM PST

Kennedy I, New York Palace Hotel, New York City

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Ed Bell

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 Lindsey Jesch Logan

E: media@ctiseattle.com T: 206.272.4347

http://www.celltherapeutics.com/press_room F: 206.272.4434


SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
2. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
6. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
7. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
8. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
9. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
10. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
11. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... years. And according to My Cleaning Products, many turn to ... However, because of the health and environmental risks those solutions ... bugs with Bed Bug Bully instead. , According ... on bed bugs as they used to be. It shared ...
(Date:5/21/2013)... Vital Imaging ™ has teamed ... San Diego for a joint study which aims to ... Resonance Imaging) with that of a supine Dynawell MRI ... of improved healthcare by combining cutting edge technology with ... valuable tool for evaluating pathological changes in the spine, ...
(Date:5/21/2013)... 2013 The Formulate Fusion Fabric Display ... sales and marketing teams looking for a fully-functional package for ... as “everything you’ll need to put together a stunning and ... with a number of displays and accessories that can be ... by 20 feet in size. These components vary from kit ...
(Date:5/20/2013)... May 20, 2013 Oven Industries Inc. ... ramp/soak capabilities. The 5R6-900 benchtop controller has many outstanding ... can be plugged into the wall as a self-contained ... This distinctive detail makes the device unique, as well ... laboratory temperature controller can also be used universally, which ...
Breaking Biology Technology:New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2
... for January for lead antibody program ... ... Research Inc. (TSX:,ARI), a biotechnology company discovering and developing the next wave ... technology transfer agreement for its CD44 Cancer,Stem Cell antibody with Avid Bioservices, ...
... ... import, ... ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) is pleased to,announce that it has received ... Oil (NKO(R)) has,obtained approval as a complementary medicine allowing immediate,commercialization in ...
... (Nasdaq: SGMO ) announced today that the company ... several of its,therapeutic programs and discuss other business matters ... held from 4:30 to 6:30 pm ET, on,Wednesday, December ... and may be accessed via a link on,the Sangamo ...
Cached Biology Technology:ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody 2ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody 3Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R) 2Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R) 3Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing 2
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... the beginning is the fertilized egg cell. Following numerous ... with different organs and tissues. The largely unexplained process ... they should later develop is an astonishing phenomenon. Scientists ... the University of Tbingen and the University of Wageningen, ...
... An experimental oral drug has lowered blood sugar levels ... the medication could someday be added to the arsenal of ... to new research. The drug consists of a synthetic ... macrophage migration inhibitory factor, or MIF. This protein is implicated ...
... at the Technische Universitt Mnchen (TUM) have developed a ... proteins on a time scale of nanoseconds to microseconds. ... method they found two structures that were otherwise barely ... for the protein function can take place in the ...
Cached Biology News:How plants put down roots 2Study points to potential new drug for type 2 diabetes 2Study points to potential new drug for type 2 diabetes 3Study points to potential new drug for type 2 diabetes 4Measuring protein movements with nanosecond resolution 2
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
...
Biology Products: